According to the changes announced by India Index Services and Products Ltd (IISL), a subsidiary of NSES trategic Investment Corporation, Ajanta Pharmaceuticals will be excluded from Nifty Midcap 50 index with effect from October 19, this year.
| Subscribe To Our Free Newsletter |
